We are live on
!
Find out more
PM
Penbrook Management Portfolio holdings
AUM
$169M
Turnover
8.49%
1-Year Est. Return
32.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.43%
1 Year Est. Return
+32.52%
3 Year Est. Return
+106.62%
5 Year Est. Return
+155.24%
10 Year Est. Return
–
AUM
$161M
AUM Growth
-$5.91M
(-3.5%)
Cap. Flow
+$866K
Cap. Flow
% of AUM
0.54%
Top 10 Holdings %
Top 10 Hldgs %
39.37%
Holding
108
New
3
Increased
14
Reduced
43
Closed
6
Avg Time Held
4.5
years
Top 10 Avg Time Held
2.9
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
|
+$1.23M |
| 2 |
Exagen
XGN
|
+$1.17M |
| 3 |
Intellicheck
IDN
|
+$1.14M |
| 4 |
Insight Molecular Diagnostics
IMDX
|
+$714K |
| 5 |
Cohu
COHU
|
+$578K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$1.26M |
| 2 |
Comfort Systems
FIX
|
+$1.01M |
| 3 |
INVE Technologies, Inc. Common Stock
INVE
|
+$816K |
| 4 |
CSLT
CASTLIGHT HEALTH, INC.
CSLT
|
+$296K |
| 5 |
Core Laboratories
CLB
|
+$289K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.85% |
| 2 | Healthcare | 20.55% |
| 3 | Financials | 10.66% |
| 4 | Industrials | 9.8% |
| 5 | Consumer Discretionary | 9.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Emerson Electric
EMR
$90.1B
| $546K | 0.34% |
5,800
-100
| -2% | -$9.98K |
2014 Q1
30 quarters
|
|
|
77
Cohu
COHU
$2.41B
| $543K | 0.34% |
+17,000
| New | +$578K |
2021 Q3
0 quarters
|
|
78
Novartis
NVS
$286B
| $528K | 0.33% |
6,460
| – | – |
2013 Q4
31 quarters
|
|
|
PVG
79
DELISTED
PRETIUM RESOURCES INC.
PVG
| $492K | 0.31% |
51,000
+900
| +2% | +$8.59K |
2016 Q2
21 quarters
|
|
80
Global Partners
GLP
$1.68B
| $480K | 0.3% |
22,680
-300
| -1% | -$6.76K |
2013 Q4
31 quarters
|
|
81
Barrett Business Services
BBSI
$789M
| $465K | 0.29% |
24,400
-400
| -2% | -$7.49K |
2015 Q4
23 quarters
|
|
82
CNX Resources
CNX
$5.31B
| $457K | 0.28% |
36,200
-500
| -1% | -$6.05K |
2021 Q1
2 quarters
|
|
83
Ford
F
$49.6B
| $430K | 0.27% |
30,375
+15,675
| +107% | +$213K |
2020 Q3
4 quarters
|
|
84
Beeline Holdings
BLNE
$25.8M
| $427K | 0.27% |
827
-9
| -1% | -$5.95K |
2019 Q3
8 quarters
|
|
|
MIN
85
Aberdeen Intermediate Income Fund
MIN
$269M
| $424K | 0.26% |
19,505
-250
| -1% | -$5.54K |
2013 Q4
31 quarters
|
|
86
DELISTED
Desktop Metal, Inc.
DM
| $421K | 0.26% |
5,875
| – | – |
2021 Q1
2 quarters
|
|
87
Invesco Municipal Trust
VKQ
$491M
| $402K | 0.25% |
30,000
| – | – |
2013 Q4
31 quarters
|
|
|
PCTI
88
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $401K | 0.25% |
64,500
| – | – |
2017 Q4
15 quarters
|
|
89
Sinclair Inc
SBGI
$905M
| $387K | 0.24% |
12,200
-200
| -2% | -$5.88K |
2018 Q2
13 quarters
|
|
90
Harvard Bioscience
HBIO
$36.8M
| $349K | 0.22% |
5,000
| – | – |
2021 Q2
1 quarter
|
|
91
John Wiley & Sons Class A
WLY
$2.67B
| $318K | 0.2% |
6,100
| – | – |
2020 Q4
3 quarters
|
|
92
DELISTED
INTRUSION INC NEW
INTZ
| $314K | 0.2% |
77,330
+250
| +0.3% | +$1.01K |
2021 Q1
2 quarters
|
|
93
Walt Disney
DIS
$191B
| $313K | 0.19% |
1,850
| – | – |
2020 Q4
3 quarters
|
|
94
Nuveen Municipal Value Fund
NUV
$1.73B
| $300K | 0.19% |
26,500
| – | – |
2019 Q3
8 quarters
|
|
95
Designer Brands
DBI
$316M
| $295K | 0.18% |
21,205
| – | – |
2015 Q4
23 quarters
|
|
96
ConocoPhillips
COP
$176B
| $279K | 0.17% |
4,120
| – | – |
2021 Q1
2 quarters
|
|
97
Ares Capital
ARCC
$13.4B
| $263K | 0.16% |
12,940
| – | – |
2020 Q2
5 quarters
|
|
98
Aflac
AFL
$60.1B
| $242K | 0.15% |
4,650
| – | – |
2020 Q4
3 quarters
|
|
|
MMX
99
DELISTED
Maverix Metals Inc. Common Shares
MMX
| $201K | 0.12% |
45,000
| – | – |
2019 Q4
7 quarters
|
|
100
Energy Transfer Partners
ET
$69.8B
| $198K | 0.12% |
20,618
| – | – |
2021 Q2
1 quarter
|
|
Similar funds
ACA
CCM
CIA
EG
ANHIM
WS
CBOR
NWMG
Penbrook Management's Q3 2021 Portfolio in Review
As of Q3 2021, Penbrook Management held 108 positions worth $161M, down 3.5% from $167M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Penbrook Management's Q3 2021 filing shows 3 new, 14 increased, 43 reduced and 6 closed positions. Its largest new stake was Atlas Technical Consultants, Inc. Class A Common Stock: 119,395 shares worth $1.21M. The largest sale was Nuance Communications, Inc., an estimated $1.26M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Penbrook Management's largest Q3 2021 buy was Atlas Technical Consultants, Inc. Class A Common Stock: 119,395 shares worth $1.21M.
- Penbrook Management added most to Intellicheck in Q3 2021, an estimated $1.14M increase.
- Penbrook Management's biggest Q3 2021 reduction was Nuance Communications, Inc., cutting an estimated $1.26M.
- Penbrook Management fully exited Comfort Systems in Q3 2021, selling an estimated $1.01M.
- Penbrook Management's ten largest holdings make up 39% of its $161M portfolio in Q3 2021.
- Penbrook Management opened 3 new positions and closed 6 in Q3 2021.
- Penbrook Management's portfolio value fell 3.5% quarter-over-quarter to $161M.
Based on Penbrook Management's 13F filing for Q3 2021, filed 26 Oct 2021.